Mus musculus Gene: Tle1
Summary
InnateDB Gene IDBG-157429.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Tle1
Gene Name transducin-like enhancer of split 1, homolog of Drosophila E(spl)
Synonyms C230057C06Rik; Estm14; Grg-1; Grg1; Tle4l
Species Mus musculus
Ensembl Gene ENSMUSG00000008305
Encoded Proteins
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
transducin-like enhancer of split 1, homolog of Drosophila E(spl)
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000196781:
Gene Information
Type Protein coding
Genomic Location Chromosome 4:72117142-72200919
Strand Reverse strand
Band C3
Transcripts
ENSMUST00000030095 ENSMUSP00000030095
ENSMUST00000072695 ENSMUSP00000072481
ENSMUST00000102848 ENSMUSP00000099912
ENSMUST00000074216 ENSMUSP00000073839
ENSMUST00000107337 ENSMUSP00000102960
ENSMUST00000132550
ENSMUST00000123259
ENSMUST00000140154 ENSMUSP00000118513
ENSMUST00000137075 ENSMUSP00000118683
ENSMUST00000134225
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 24 experimentally validated interaction(s) in this database.
They are also associated with 96 interaction(s) predicted by orthology.
Experimentally validated
Total 24 [view]
Protein-Protein 17 [view]
Protein-DNA 7 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 96 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0001106 RNA polymerase II transcription corepressor activity
GO:0003682 chromatin binding
GO:0003714 transcription corepressor activity
GO:0005515 protein binding
GO:0008134 transcription factor binding
Biological Process
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0010628 positive regulation of gene expression
GO:0016055 Wnt signaling pathway
GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling
GO:0045892 negative regulation of transcription, DNA-templated
GO:2000811 negative regulation of anoikis
Cellular Component
GO:0005634 nucleus
GO:0005667 transcription factor complex
GO:0005730 nucleolus
GO:0005737 cytoplasm
GO:0005829 cytosol
Orthologs
Species
Homo sapiens
Gene ID
Gene Order
Pathways
NETPATH
REACTOME
Disease pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Signaling by Wnt pathway
Signaling by WNT in cancer pathway
Degradation of beta-catenin by the destruction complex pathway
repression of WNT target genes pathway
AMER1 mutants destabilize the destruction complex pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
deactivation of the beta-catenin transactivating complex pathway
formation of the beta-catenin:TCF transactivating complex pathway
APC truncation mutants have impaired AXIN binding pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Signaling by NOTCH1 pathway
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
AXIN missense mutants destabilize the destruction complex pathway
TCF dependent signaling in response to WNT pathway
Signaling by NOTCH1 in Cancer pathway
Signaling by NOTCH1 HD Domain Mutants in Cancer pathway
Signaling by NOTCH1 PEST Domain Mutants in Cancer pathway
FBXW7 Mutants and NOTCH1 in Cancer pathway
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer pathway
APC truncation mutants are not K63 polyubiquitinated pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
TCF7L2 mutants don't bind CTBP pathway
truncations of AMER1 destabilize the destruction complex pathway
NOTCH1 Intracellular Domain Regulates Transcription pathway
Signal Transduction pathway
truncated APC mutants destabilize the destruction complex pathway
Signaling by NOTCH pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
KEGG
INOH
Wnt signaling pathway pathway
TGF-beta signaling pathway
PID NCI
Pathway Predictions based on Human Orthology Data
NETPATH
REACTOME
NOTCH1 Intracellular Domain Regulates Transcription pathway
Degradation of beta-catenin by the destruction complex pathway
truncated APC mutants destabilize the destruction complex pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
APC truncation mutants are not K63 polyubiquitinated pathway
AMER1 mutants destabilize the destruction complex pathway
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
Signaling by WNT in cancer pathway
AXIN missense mutants destabilize the destruction complex pathway
Signaling by Wnt pathway
Signaling by NOTCH1 in Cancer pathway
APC truncation mutants have impaired AXIN binding pathway
deactivation of the beta-catenin transactivating complex pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
FBXW7 Mutants and NOTCH1 in Cancer pathway
Signal Transduction pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Signaling by NOTCH1 PEST Domain Mutants in Cancer pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
truncations of AMER1 destabilize the destruction complex pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
TCF dependent signaling in response to WNT pathway
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer pathway
Signaling by NOTCH pathway
repression of WNT target genes pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Signaling by NOTCH1 pathway
Signaling by NOTCH1 HD Domain Mutants in Cancer pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
TCF7L2 mutants don't bind CTBP pathway
formation of the beta-catenin:TCF transactivating complex pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
Disease pathway
KEGG
INOH
Wnt signaling pathway pathway
TGF-beta signaling pathway
PID NCI
Presenilin action in Notch and Wnt signaling
Notch-mediated HES/HEY network
Regulation of nuclear beta catenin signaling and target gene transcription
Cross-References
SwissProt
TrEMBL Q5SQA7
UniProt Splice Variant
Entrez Gene 21885
UniGene Mm.278444 Mm.404851
RefSeq NM_001285529 NM_001285531 NM_001285532 NM_011599 XM_006537758 XM_006537759 XM_006537760 XM_006537761 XM_006537763 XM_006537765 XM_006537767
OMIM
CCDS CCDS18274 CCDS71407
HPRD
IMGT
MGI ID MGI:104636
MGI Symbol Tle1
EMBL AL773513 BX640475
GenPept
RNA Seq Atlas 21885